Navigation Links
Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR

ials of its product candidates, the Company's ability to develop a modified release formulation of CRx-102, potential difficulty and delays in obtaining regulatory approval for the sale and marketing of its product candidates, the Company's ability to obtain additional financing or funding for its research and development and those other risks that can be found in the "Risk Factors" section of the CombinatoRx Annual Report on Form 10-K on file with the Securities and Exchange Commission and the other reports that CombinatoRx periodically files with the Securities and Exchange Commission. Actual results may differ materially from those CombinatoRx contemplated by these forward-looking statements. CombinatoRx does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this release.

(c) 2007 CombinatoRx, Incorporated. All rights reserved.

Contact

CombinatoRx, Incorporated
Robert Forrester, 617-301-7100
EVP, Chief Financial Officer
rforrester@combinatorx.com
or
Gina Nugent, 617-301-7099
VP, Corporate Communications and IR
gnugent@combinatorx.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
4. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
5. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
6. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
7. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:4/19/2015)... , April 19, 2015  Blueprint Medicines today ... candidate BLU-285 has significant anti-tumor activity in treatment-resistant ... and maintained complete tumor regression in all mice ... were presented at the American Association for Cancer ... advances in treating GIST, there are still subsets ...
(Date:4/17/2015)... /CNW/ - The issue: In ... one lot (lot 710535) of Clavulin-400 (70mL) after receiving a ... found in one bottle of the  product. No other lots ... Clavulin-400 is an oral antibiotic used in adults and ... infections. Clavulin-400 comes as a powder in bottles and is ...
(Date:4/17/2015)... Contego Medical, the first and only ... for angioplasty balloon and stent delivery catheters, announces ... financing round led by Hatteras Venture Partners, an ... medical devices, biopharmaceuticals, diagnostics and related opportunities in ... Partners, Lookout Capital and Medical Mutual. ...
Breaking Medicine Technology:Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 2Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 3Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 4Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3
... ANGELES, March 3, 2011 InstaCare Corp. (OTC Bulletin ... prescription drugs, home testing products for the chronically ill, ... programs, and a leading developer of revolutionary patent pending ... today announced that it has migrated its recently patent ...
... Virtual Radiologic (vRad), a technology-enabled national ... Central Illinois-based radiology practice serving Champaign/Urbana, Effingham, ... of a strategic alliance, merging Lakeland with ... practice will be called Lakeland Radiology Alliance, ...
Cached Medicine Technology:InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 3Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 2Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 3
(Date:4/19/2015)... has released a new blog post explaining what motorcycles ... plan . , Motorcycles can be difficult to ... auto insurance plans. Insurance brokers have gathered a list ... cheaper to insure. , The budget that a ... auto insurance plan that he/she will buy. When comparing ...
(Date:4/19/2015)... has released a new blog post explaining that ... family members. , Accidental death and dismemberment insurance ... in an accident. The policy will cover car accidents ... plan. However, AD&D insurance can also be an independent ... The newly blog post presents the advantages of owning ...
(Date:4/19/2015)... Fla. (PRWEB) April 19, 2015 The ... DO, MPH, MHCM, FACS, as the inaugural winner of ... at its annual meeting, April 18, in Las Vegas, ... Medical Group, vice chairman of the department of surgery ... and Medical Center in Hartford, Connecticut, was instrumental in ...
(Date:4/19/2015)... April 19, 2015 Broccoli sprout extract ... in a small group of healthy human volunteers, the ... with UPMC CancerCenter , announced today at the ... Meeting in Philadelphia. , The promising results will ... will recruit participants at high risk for head and ...
(Date:4/19/2015)... Carinsurancehints.com has released a new blog post providing a ... insurance benefits . , Drivers who were involved in ... information for claiming auto insurance benefits. Exchanging insurance information is ... most of the damages. The newly released blog post explains ... , Drivers can compare online rates and find the best ...
Breaking Medicine News(10 mins):Health News:Buying Auto Insurance for Motorcycles - Models That Are Cheap to Cover! 2Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2
... properties of bacteria to form barrier against illness , , ... Polytechnic Institute say that have solved the mystery of ... study, published in the current issue of Colloids ... the thermodynamic properties of bacteria in the urinary tract ...
... National Institutes of Health has awarded $128 million to ... Jeffrey Krischer, PhD, to coordinate worldwide studies on the ... a seven-year award, supports Dr. Krischer,s coordination of the ... , The award adds to the $169 million received ...
... Masimo provides Aurora with technology and sensor standardization ... its facilities - creating efficiencies and cost savings, ... inventor,of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse,Oximetry, announced that ... Masimo SET pulse oximetry technology. The integrated health,care ...
... As tens of thousands of Americans,prepare to attend the ... injury or illness -- and how to deal with ... adequate, appropriate medical care in foreign lands can be,daunting, ... themselves,peace of mind," said Angelo Masciantonio, CEO and co-founder ...
... 31 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ... products and services in the People,s Republic of ... fiscal 2009 first quarter,financial results on Thursday, August ... a conference call at 8:00 am ET that ...
... Feat could one day lead to tailor-made cells to treat ... -- Scientists have turned skin cells from patients with Lou ... the patients, own neurons. , An unlimited number of these ... a capability which should result in a better understanding of ...
Cached Medicine News:Health News:Study Explains How Cranberries Prevent Urinary Infections 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Americans Attending Beijing Olympics Should Plan Ahead for Medical Emergencies 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 3Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... of DNA, RNA, Or Fluorescent Tags. Accurate quantitation ... critical to life science research. The RF-Mini 150 ... quantities as small as 1ng/ml of DNA specific ... excitation and emission filters, the RF-Mini 150 can ...
Medicine Products: